Pathway Reinforcement and Chassis Optimization of Escherichia coli BL21 for Enhancing Lacto‑N‑tetraose Production
Applied Biochemistry and Biotechnology · 2025
DOI: 10.1007/s12010-025-05397-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Biochemistry and Biotechnology, 2025. Verfasst von Xinyue Su und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Anhui University, 230601, Hefei, China. Hauptthemen laut MEDLINE: Escherichia coli, Oligosaccharides, Lactose, Metabolic Engineering. Die Arbeit nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Lacto‑N‑tetraose (LNT) is an important neutral non-fucosylated form of human milk oligosaccharides, widely recognized for its protective effects on infant health and enhancement of immune functions. In this study, to reinforce the fermentative synthesis of LNT, lactose utilization was enhanced for LNT production through overexpressing lacY (encoding the lactose permease gene) in Escherichia coli BL21, which can achieve the LNT titer and productivity of 1.55 g/L and 0.02 g/L/h, respectively. Moreover, the chassis was optimized through deleting byproduct genes: wecB (encoding UDP-N-acetyl glucosamine-2-epimerase), lacZ (encoding β-galactosidase), and the nagB gene (encoding glucosamine-6-phosphate deaminase), so we can obtain a 2.8 g/L LNT titer and 0.039 g/L/h productivity. Furthermore, we designed the UTP regeneration for precursor production through overexpressing the ndk gene (encoding nucleoside diphosphate kinase) and increased the LNT titer by 3.02 g/L. Finally, the LNT titer and productivity were improved to 3.22 g/L and 0.05 g/L/h by integrating the LgtA-WbgO expression cassette in the genome. This study establishes a stepwise optimization strategy in Escherichia coli BL21 for LNT biosynthesis, providing a foundation for industrial-scale production.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Anhui University, 230601, Hefei, China.
- Key Laboratory of Human Microenvironment and Precision Medicine of Anhui Higher Education Institutes, Anhui University, 230601, Hefei , Anhui, China.
- School of Life Sciences, Anhui University, 230601, Hefei, China. yzwang@ahu.edu.cn.
- Key Laboratory of Human Microenvironment and Precision Medicine of Anhui Higher Education Institutes, Anhui University, 230601, Hefei , Anhui, China. yzwang@ahu.edu.cn.
- Anhui Province Joint Construction Discipline Key Laboratory of Nanobody Technology, Hefei, China. yzwang@ahu.edu.cn.
- Anhui Healcurer Heath Biotech Co., Ltd. - Anhui University Joint Postgraduate Training Base of Anhui Province, Hefei, China. yzwang@ahu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Su, X., Wang, Y., & Ding, Q. (2025). Pathway Reinforcement and Chassis Optimization of Escherichia coli BL21 for Enhancing Lacto‑N‑tetraose Production. Applied Biochemistry and Biotechnology. https://doi.org/10.1007/s12010-025-05397-9
Vancouver
Su X, Wang Y, Ding Q. Pathway Reinforcement and Chassis Optimization of Escherichia coli BL21 for Enhancing Lacto‑N‑tetraose Production. Applied Biochemistry and Biotechnology. 2025. doi:10.1007/s12010-025-05397-9
BibTeX
@article{Su2025,
author = {Su, Xinyue and Wang, Yongzhong and Ding, Qiang},
title = {Pathway Reinforcement and Chassis Optimization of Escherichia coli BL21 for Enhancing Lacto‑N‑tetraose Production},
journal = {Applied Biochemistry and Biotechnology},
year = {2025},
doi = {10.1007/s12010-025-05397-9}
}
EUVIMED